331 – 340 of 2053
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer : promise, controversies and ambiguities in the novel treatment paradigm
(
- Contribution to journal › Scientific review
-
Mark
Hydroethanolic Extract of Solanum paniculatum L. Fruits Modulates ROS and Cytokine in Human Cell Lines
2020) In Oxidative Medicine and Cellular Longevity(
- Contribution to journal › Article
-
Mark
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
(
- Contribution to journal › Article
-
Mark
Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion
2020) In Journal of Molecular Neuroscience(
- Contribution to journal › Article
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
(
- Contribution to journal › Article
-
Mark
Use of potentially inappropriate medication and polypharmacy in older adults : a repeated cross-sectional study
(
- Contribution to journal › Article
-
Mark
CGRP in rat mesenteric artery and vein - receptor expression, CGRP presence and potential roles
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, methyl 3-hydroxyhexanoate, CAS Registry Number 21188-58-9
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, N-(2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide, CAS Registry Number 847565-09-7
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, cis-3-hexenyl cis-3-hexenoate, CAS Registry Number 61444-38-0
(
- Contribution to journal › Article